CCL18 and cancer: Notably, the cytokine CCL18 (also known as PARC) previously showed the strongest association with mortality among 28 SASPs in a study of 1923 individuals over the age of 6559, and has been associated with disease-progression or negative outcomes in a range of diseases including cancer 60, atherosclerosis 61, and lung disease 62.